Principal Financial Group
ADMS

Principal Financial Group’s Adamas Pharmaceuticals ADMS Stock Holding History

Principal Financial Group’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-63,167
Closed -$310K – 2703
2021
Q3 		$310K Sell
63,167
-474
-0.7% -$2.3K ﹤0.01% 2294
2021
Q2 		$336K Buy
+63,641
New +$329K ﹤0.01% 2323

Principal Financial Group's ADMS Position: Q4 2021 in Review

Principal Financial Group sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 63,167 shares — an estimated $310K sold.

Principal Financial Group first reported a position in ADMS in Q2 2021 and held it in 2 quarters. The position peaked at $336K in Q2 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

  • Principal Financial Group reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Principal Financial Group sold 63,167 Adamas Pharmaceuticals shares in Q4 2021, an estimated $310K.
  • Principal Financial Group first reported a position in Adamas Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Principal Financial Group's Adamas Pharmaceuticals position peaked at $336K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Principal Financial Group's 13F filing for Q4 2021, filed 9 Feb 2022.